Clinical feasibility of CS-VIBE accelerates MRI techniques in diagnosing intracranial metastasis

Abstract Our objective was to evaluate and compare the diagnostic performance of post-contrast 3D compressed-sensing volume-interpolated breath-hold examination (CS-VIBE) and 3D T1 magnetization-prepared rapid-acquisition gradient-echo (MPRAGE) in detecting intracranial metastasis. Additionally, we...

Full description

Bibliographic Details
Main Authors: Sang Ik Park, Younghee Yim, Mi Sun Chung
Format: Article
Language:English
Published: Nature Portfolio 2023-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-37148-3
_version_ 1797795716326752256
author Sang Ik Park
Younghee Yim
Mi Sun Chung
author_facet Sang Ik Park
Younghee Yim
Mi Sun Chung
author_sort Sang Ik Park
collection DOAJ
description Abstract Our objective was to evaluate and compare the diagnostic performance of post-contrast 3D compressed-sensing volume-interpolated breath-hold examination (CS-VIBE) and 3D T1 magnetization-prepared rapid-acquisition gradient-echo (MPRAGE) in detecting intracranial metastasis. Additionally, we analyzed and compared the image quality between the two. We enrolled 164 cancer patients who underwent contrast-enhanced brain MRI. Two neuroradiologists independently reviewed all the images. The signal-to-noise ratio (SNR), contrast-to noise ratio (CNR) were compared between two sequences. For patients with intracranial metastasis, we measured enhancement degree and CNRlesion/parenchyma of the lesion. The overall image quality, motion artifact, gray-white matter discrimination and enhancing lesion conspicuity were analyzed. Both MPRAGE and CS-VIBE showed similar performance in diagnosing intracranial metastasis. Overall image quality of CS-VIBE was better with less motion artifact; however conventional MPRAGE was superior in enhancing lesion conspicuity. Overall, the SNR and CNR of conventional MPRAGE were higher than those of CS-VIBE. For 30 enhancing intracranial metastatic lesions, MPRAGE showed a lower CNR (p = 0.02) and contrast ratio (p = 0.03). MPRAGE and CS-VIBE were preferred in 11.6 and 13.4% of cases, respectively. In comparison with conventional MPRAGE, CS-VIBE achieved comparable image quality and visualization, with the scan time being half of that of MPRAGE.
first_indexed 2024-03-13T03:22:14Z
format Article
id doaj.art-76522ba18a544e92801cd1f94f722b70
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-13T03:22:14Z
publishDate 2023-06-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-76522ba18a544e92801cd1f94f722b702023-06-25T11:15:38ZengNature PortfolioScientific Reports2045-23222023-06-0113111010.1038/s41598-023-37148-3Clinical feasibility of CS-VIBE accelerates MRI techniques in diagnosing intracranial metastasisSang Ik Park0Younghee Yim1Mi Sun Chung2Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of MedicineDepartment of Radiology, Chung-Ang University Hospital, Chung-Ang University College of MedicineDepartment of Radiology, Human Medical Imaging and Intervention CenterAbstract Our objective was to evaluate and compare the diagnostic performance of post-contrast 3D compressed-sensing volume-interpolated breath-hold examination (CS-VIBE) and 3D T1 magnetization-prepared rapid-acquisition gradient-echo (MPRAGE) in detecting intracranial metastasis. Additionally, we analyzed and compared the image quality between the two. We enrolled 164 cancer patients who underwent contrast-enhanced brain MRI. Two neuroradiologists independently reviewed all the images. The signal-to-noise ratio (SNR), contrast-to noise ratio (CNR) were compared between two sequences. For patients with intracranial metastasis, we measured enhancement degree and CNRlesion/parenchyma of the lesion. The overall image quality, motion artifact, gray-white matter discrimination and enhancing lesion conspicuity were analyzed. Both MPRAGE and CS-VIBE showed similar performance in diagnosing intracranial metastasis. Overall image quality of CS-VIBE was better with less motion artifact; however conventional MPRAGE was superior in enhancing lesion conspicuity. Overall, the SNR and CNR of conventional MPRAGE were higher than those of CS-VIBE. For 30 enhancing intracranial metastatic lesions, MPRAGE showed a lower CNR (p = 0.02) and contrast ratio (p = 0.03). MPRAGE and CS-VIBE were preferred in 11.6 and 13.4% of cases, respectively. In comparison with conventional MPRAGE, CS-VIBE achieved comparable image quality and visualization, with the scan time being half of that of MPRAGE.https://doi.org/10.1038/s41598-023-37148-3
spellingShingle Sang Ik Park
Younghee Yim
Mi Sun Chung
Clinical feasibility of CS-VIBE accelerates MRI techniques in diagnosing intracranial metastasis
Scientific Reports
title Clinical feasibility of CS-VIBE accelerates MRI techniques in diagnosing intracranial metastasis
title_full Clinical feasibility of CS-VIBE accelerates MRI techniques in diagnosing intracranial metastasis
title_fullStr Clinical feasibility of CS-VIBE accelerates MRI techniques in diagnosing intracranial metastasis
title_full_unstemmed Clinical feasibility of CS-VIBE accelerates MRI techniques in diagnosing intracranial metastasis
title_short Clinical feasibility of CS-VIBE accelerates MRI techniques in diagnosing intracranial metastasis
title_sort clinical feasibility of cs vibe accelerates mri techniques in diagnosing intracranial metastasis
url https://doi.org/10.1038/s41598-023-37148-3
work_keys_str_mv AT sangikpark clinicalfeasibilityofcsvibeacceleratesmritechniquesindiagnosingintracranialmetastasis
AT youngheeyim clinicalfeasibilityofcsvibeacceleratesmritechniquesindiagnosingintracranialmetastasis
AT misunchung clinicalfeasibilityofcsvibeacceleratesmritechniquesindiagnosingintracranialmetastasis